360iResearch Logo
Global Vaccine Vials Market
Report Code: MRR-50AD613 | Publishing Date: September 2020 | Number of Pages: 169

The Global Vaccine Vials Market to grow from USD 421.57 Million in 2019 to USD 745.22 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 9.96%.

Market Segmentation & Coverage:

The research report categorizes the Vaccine Vials Market to forecast the revenues and analyze the trends in each of the following segments:

Based on Type, the Vaccine Vials Market studied across Multi Dose and Single Dose.

Based on Material, the Vaccine Vials Market studied across Glass and Polymer.

Based on Capacity, the Vaccine Vials Market studied across 10ml, 20ml, 2ml, 3ml, and 5ml.

Based on Application, the Vaccine Vials Market studied across Preventive Vaccine and Therapeutic Vaccine.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Vaccine Vials Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Vaccine Vials Market in 2019, followed by the Americas. On the other hand, the Asia-Pacific expected to grow at the fastest CAGR during the forecast period, followed by the Europe, Middle East & Africa.

Market Dynamics:

The factors attributing to the growth of the market are growing initiatives from government and private organizations to advance vaccination, increasing demand for a large number of vaccines for the sales of vaccine vials, and high prevalence of infectious diseases and rise of pharmaceutical industries. However, some factors such as lack of healthcare infrastructure in developing countries such as brazil, india, and china may hinder the market growth. The Vaccine Vials Market expected to showcase the opportunities such as rising awareness of immunization among the people regarding the endemic diseases, attractive investment in vaccine vial monitor (vvm), and development of innovative vaccine administration methods. Soon market may face the possible challenges in the growth due to high-cost associated with the supply chain of vaccine vials. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the market.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch Competitive Strategic Window:

The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

360iResearch FPNV Positioning Matrix:

The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Vials Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Company Usability Profiles:

The Vaccine Vials Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increased competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Vials Market, including Anhui Huaxin Medicinal Glass Products Co., Ltd., Berlin Packaging LLC, Cardinal Health, Inc., Catalent, Inc., Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co., Ltd., JOTOP Glass, Nipro Corporation, Origin Pharmaceuticals Ltd, Pacific Vial Manufacturing Inc., Qorpak, Inc., Richland Glass Company, Inc., SCHOTT AG, Shandong Pharmaceutical Glass Co., Ltd., SiO2 Medical Products, Stevanato Group, Thermo Fisher Scientific Inc, and Vetter Pharma-Fertigung GmbH & Co. KG..

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
      8. Repeat: Report Update
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
  3. Executive Summary
    1. Introduction
    2. Market Outlook
    3. Type Outlook
    4. Application Outlook
    5. Material Outlook
    6. Capacity Outlook
    7. Geography Outlook
    8. Competitor Outlook
  4. Market Overview
    1. Introduction
  5. Market Dynamics
    1. Introduction
    2. Drivers
      1. Increasing demand for a large number of vaccines for the sales of vaccine vials
      2. High prevalence of infectious diseases and rise of pharmaceutical industries
      3. Growing initiatives from government and private organizations to advance vaccination
    3. Restraints
      1. Lack of healthcare infrastructure in developing countries such as Brazil, India, and China
    4. Opportunities
      1. Rising awareness of immunization among the people regarding the endemic diseases
      2. Development of innovative vaccine administration methods
      3. Attractive investment in Vaccine vial monitor (VVM)
    5. Challenges
      1. High-cost associated with the supply chain of vaccine vials
  6. Market Insights
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
      1. Value Chain Analysis
  7. Global Vaccine Vials Market, By Type
    1. Introduction
    2. Multi Dose
    3. Single Dose
  8. Global Vaccine Vials Market, By Material
    1. Introduction
    2. Glass
    3. Polymer
  9. Global Vaccine Vials Market, By Capacity
    1. Introduction
    2. 10ml
    3. 20ml
    4. 2ml
    5. 3ml
    6. 5ml
  10. Global Vaccine Vials Market, By Application
    1. Introduction
    2. Preventive Vaccine
    3. Therapeutic Vaccine
  11. Americas Vaccine Vials Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  12. Asia-Pacific Vaccine Vials Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  13. Europe, Middle East & Africa Vaccine Vials Market
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  14. Competitive Landscape
    1. FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
      3. Product Satisfaction
    2. Market Ranking Analysis
    3. Market Share Analysis
    4. Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration, & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
      5. Award, Recognition, & Expansion
  15. Company Usability Profiles
    1. Anhui Huaxin Medicinal Glass Products Co., Ltd.
    2. Berlin Packaging LLC
    3. Cardinal Health, Inc.
    4. Catalent, Inc.
    5. Corning Inc.
    6. DWK Life Sciences GmbH
    7. Gerresheimer AG
    8. Jinan Youlyy Industrial Co., Ltd.
    9. JOTOP Glass
    10. Nipro Corporation
    11. Origin Pharmaceuticals Ltd
    12. Pacific Vial Manufacturing Inc.
    13. Qorpak, Inc.
    14. Richland Glass Company, Inc.
    15. SCHOTT AG
    16. Shandong Pharmaceutical Glass Co., Ltd.
    17. SiO2 Medical Products
    18. Stevanato Group
    19. Thermo Fisher Scientific Inc
    20. Vetter Pharma-Fertigung GmbH & Co. KG.
  16. Appendix
    1. Discussion Guide

List of Tables

  1. GLOBAL VACCINE VIALS MARKET SIZE, 2017-2025 (USD MILLION)
  2. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  3. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  4. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  7. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  10. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  11. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  12. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  14. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  16. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  20. AMERICAS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  21. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  22. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  23. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  24. ARGENTINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  25. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  26. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  27. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  28. BRAZIL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  29. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  30. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  31. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  32. CANADA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  33. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  34. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  35. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  36. MEXICO VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  37. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  38. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  39. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  40. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  41. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  42. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  43. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  44. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  45. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  46. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  47. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  48. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  49. AUSTRALIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  50. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  51. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  52. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  53. CHINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  54. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  55. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  56. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  57. INDIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  58. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  59. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  60. INDONESIA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  61. INDONESIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  62. INDONESIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  63. INDONESIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  64. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  65. JAPAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  66. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  67. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  68. MALAYSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  69. MALAYSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  70. MALAYSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  71. MALAYSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  72. PHILIPPINES VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  73. PHILIPPINES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  74. PHILIPPINES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  75. PHILIPPINES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  76. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  77. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  78. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  79. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  80. THAILAND VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  81. THAILAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  82. THAILAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  83. THAILAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  84. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  85. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  86. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  87. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  88. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  89. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  90. FRANCE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  91. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  92. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  93. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  94. GERMANY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  95. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  96. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  97. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  98. ITALY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  99. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  100. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  101. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  102. NETHERLANDS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  103. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  104. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  105. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  106. QATAR VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  107. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  108. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  109. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  110. RUSSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  111. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  112. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  113. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  114. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  115. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  116. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  117. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  118. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  119. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  120. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  121. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  122. SPAIN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  123. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  124. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  125. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  126. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  127. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  128. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  129. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  130. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  131. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2017-2025 (USD MILLION)
  132. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2017-2025 (USD MILLION)
  133. GLOBAL VACCINE VIALS MARKET: SCORES
  134. GLOBAL VACCINE VIALS MARKET: BUSINESS STRATEGY
  135. GLOBAL VACCINE VIALS MARKET: PRODUCT SATISFACTION
  136. GLOBAL VACCINE VIALS MARKET: RANKING
  137. GLOBAL VACCINE VIALS MARKET: MERGER & ACQUISITION
  138. GLOBAL VACCINE VIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  139. GLOBAL VACCINE VIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  140. GLOBAL VACCINE VIALS MARKET: INVESTMENT & FUNDING
  141. GLOBAL VACCINE VIALS MARKET: AWARD, RECOGNITION, & EXPANSION

List of Figures

  1. GLOBAL VACCINE VIALS MARKET: RESEARCH PROCESS
  2. GLOBAL VACCINE VIALS MARKET: RESEARCH EXECUTION
  3. GLOBAL VACCINE VIALS MARKET SIZE, 2019 VS 2025 (USD MILLION)
  4. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2019 VS 2025 (USD MILLION)
  5. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
  6. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019 VS 2025 (USD MILLION)
  7. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019 VS 2025 (USD MILLION)
  8. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  9. GLOBAL VACCINE VIALS MARKET SIZE, 2017-2025 (USD MILLION)
  10. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  11. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
  13. GLOBAL VACCINE VIALS MARKET: MARKET DYNAMICS
  14. GLOBAL VACCINE VIALS MARKET: PORTERS FIVE FORCES ANALYSIS
  15. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2019 VS 2025 (%)
  16. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2019 VS 2025 (USD MILLION)
  17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2025
  18. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, 2019 VS 2025 (USD MILLION)
  19. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, 2019 VS 2025 (USD MILLION)
  20. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019 VS 2025 (%)
  21. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019 VS 2025 (USD MILLION)
  22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025
  23. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, 2019 VS 2025 (USD MILLION)
  24. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, 2019 VS 2025 (USD MILLION)
  25. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019 VS 2025 (%)
  26. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019 VS 2025 (USD MILLION)
  27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025
  28. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, 2019 VS 2025 (USD MILLION)
  29. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, 2019 VS 2025 (USD MILLION)
  30. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, 2019 VS 2025 (USD MILLION)
  31. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, 2019 VS 2025 (USD MILLION)
  32. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, 2019 VS 2025 (USD MILLION)
  33. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (%)
  34. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
  35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2025
  36. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, 2019 VS 2025 (USD MILLION)
  37. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, 2019 VS 2025 (USD MILLION)
  38. AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  39. AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
  41. ARGENTINA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  42. BRAZIL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  43. CANADA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  44. MEXICO VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  45. UNITED STATES VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  46. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  47. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
  49. AUSTRALIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  50. CHINA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  51. INDIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  52. INDONESIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  53. JAPAN VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  54. MALAYSIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  55. PHILIPPINES VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  56. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  57. THAILAND VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  58. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  59. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  60. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
  61. FRANCE VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  62. GERMANY VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  63. ITALY VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  64. NETHERLANDS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  65. QATAR VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  66. RUSSIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  67. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  68. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  69. SPAIN VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  70. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  71. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  72. GLOBAL VACCINE VIALS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  73. GLOBAL VACCINE VIALS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
  74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VACCINE VIALS MARKET, BY TYPE